Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 636-644, Vol. 66, No. 2
Departments of Medical
Microbiology,1
Pediatrics,2
Ophthalmology,3 and
Electron
Microscopy,4 University of Lund, S-22185 Lund,
Sweden, and
Istituto Superiore di Sanità, Laboratorio di
Medicina Veterinaria, 00161 Rome, Italy5
Received 6 August 1997/Returned for modification 18 September
1997/Accepted 17 November 1997
This study examined apoptotic cell death associated with Shiga-like
toxin (Stx)-producing Escherichia coli. Renal cortices from
three children with postenteropathic hemolytic-uremic syndrome (HUS)
and from mice infected with E. coli O157:H7 and pediatric renal tubular epithelial cells stimulated with Stx and E. coli O157:H7 extracts were examined for apoptotic changes.
Apoptotic cells were detected by terminal dUTP nick end labeling of
tubuli and glomeruli from HUS patients and from mice inoculated with Stx-2-positive and Stx-negative strains. Apoptosis was more extensive and severe ultramorphological nuclear and cytoplasmic changes were seen
in the Stx-2-positive group. Stx caused DNA fragmentation and
ultramorphological changes indicating apoptosis in cultured pediatric
tubular cells. DNA fragmentation increased when cells were
prestimulated with tumor necrosis factor alpha. Polymyxin extracts from
Stx-2-positive and Stx-negative strains induced DNA fragmentation, but
only extracts from Stx-2-positive strains caused ultramorphological
changes and extensive DNA fragmentation. The results indicate that HUS
is accompanied by increased apoptosis of kidney cells and that
bacterial factors, possibly together with host cytokines in vivo, may
activate apoptotic tissue injury.
Hemolytic-uremic syndrome (HUS) is
characterized by microangiopathic hemolytic anemia, thrombocytopenia,
and acute renal failure. The syndrome has been divided into two forms:
typical (or postenteropathic) and atypical (28). The
postenteropathic form of HUS occurs due to infection with Shiga-like
toxin (Stx)-producing Escherichia coli, which causes a
prodrome of diarrhea or hemorrhagic colitis followed by HUS (3,
22). Stx-producing E. coli O157:H7 has been associated
with outbreaks of these conditions (15). The atypical form
of HUS is not caused by Stx-producing E. coli and is usually
not preceded by a diarrheal prodrome (10).
The most extensive tissue damage in HUS occurs in the kidneys. The
injury is most prominent in the renal cortex, with pathological changes
occurring in the glomerular endothelial cells and also in the tubular
epithelial cells (16). The mechanism by which Stx-producing
E. coli causes tissue damage is not clear. E. coli O157:H7 has not been found to be invasive (33),
and it has therefore been assumed that tissue damage occurs as a result
of the spread of bacterial products and/or inflammatory mediators from
the intestine to target organs (14). Previous studies found
that Stx-producing strains cause systemic symptoms in animals (5,
11, 39, 48, 51, 52) and that these symptoms could be reproduced when the animals were injected with purified Stx (2, 18, 47). In a recent study carried out with mice, we found that E. coli O157:H7 that produced Stx caused glomerular and
tubular pathology and a higher frequency of systemic symptoms than
E. coli O157:H7 that did not produce Stx, suggesting that
this toxin may be important for the HUS-related virulence of the strain
(24). Furthermore, in vitro studies have found that Stx is
cytotoxic for human endothelial cells (27, 36, 49) and that
renal endothelial cells are more susceptible to the cytotoxic effect than umbilical vein endothelial cells (37). After binding to cells, the toxin is endocytosed (44), binds to 60S
ribosomes, and inhibits peptide chain elongation and protein synthesis
(38, 43), thereby leading to cell death.
Programmed cell death, or apoptosis, is defined by the cell's
ultrastructural morphology (26) and is characterized by cell shrinkage, membrane blebbing, and condensation of nuclear chromatin. The morphological changes are accompanied by DNA fragmentation. This
form of cell death is a naturally occurring process by which an
organism removes damaged or unnecessary cells and may also be triggered
by external stimuli (32). Shigella flexneri
(56) has been found to induce apoptosis in host macrophages.
This activity was related to the invasive properties of the strain
(8, 56) and not the production of toxin. Purified toxins
such as diphtheria toxin (6), ricin, and Stx (45)
have previously been found to activate apoptosis. Stx induced apoptosis
in Burkitt lymphoma cells and Vero cells in vitro (19, 31)
and in rabbit intestinal epithelial cells in vivo (25). In
addition, plasma samples from patients with atypical HUS, but not from
a patient with postenteropathic HUS, were found to induce apoptosis of
human microvascular endothelial cells (34).
The aims of this study were to examine kidney tissue from patients with
postenteropathic HUS and mice with experimental E. coli
O157:H7 infection for signs of apoptosis and to study apoptosis induction in pediatric kidney cultures in vitro.
Renal tissue specimens from renal biopsies and autopsies of
patients and a pediatric control.
Renal cortical tissues from four
children were studied. A renal cortical biopsy (n = 1)
and postmortem tissues (n = 2) were available from
three children with postenteropathic HUS. A renal cortical biopsy
specimen from one child with nephrotic syndrome was studied as a
control.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Apoptosis of Renal Cortical Cells in the
Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
Mouse kidneys. Kidneys were taken from 159 C3H/HeN mice. Of these mice, 114 were studied previously (24) and 45 were studied as integral parts of this investigation. Mice were inoculated intragastrically with E. coli O157:H7 strains that produce Stx-2 (86-24 and 86BL, n = 77) (15, 24), E. coli O157:H7 strains that do not produce Stx (87-23 and 87BL, n = 42) (15, 24), or the control E. coli strain FN414 (n = 8) (17), or they were treated with PBS (0.06 M, pH 7.2; n = 8). Furthermore, 31 mice inoculated with a Stx-2-producing strain (86BL) were pretreated with a monoclonal antibody (MAb) to the Stx-2 A subunit at 70 µg/ml (n = 16) or 400 µg/ml (n = 15) (24, 40) prior to infection. Mice were examined for systemic symptoms and sacrificed when they were terminally ill or after 10 days if they were asymptomatic, as previously described (24). This study was approved by the animal ethics committee, University of Lund, Lund, Sweden.
Kidneys from 30 of the mice were selected for histology and the TUNEL assay. Eleven kidneys were taken from mice inoculated with Stx-2-positive strains. Nine kidneys were taken from mice inoculated with Stx-2-negative strains, and two were taken from mice inoculated with E. coli FN414. Kidneys from four PBS control mice were studied. In addition, kidneys from four mice pretreated with MAb to the Stx-2 A subunit and inoculated with a Stx-2-positive strain were studied. Two mice were pretreated with 70 µg of MAb per ml, and two were pretreated with 400 µg of MAb per ml. Transmission electron microscopy (TEM) was carried out with the renal cortices of 18 mice; all but four of these kidneys were also examined by light microscopy and the TUNEL assay. Eight mice were inoculated with E. coli 86-24, and seven mice were inoculated with E. coli 87-23. Renal cortices from three PBS controls were also examined. Tubular epithelial cells were identified by the presence of microvilli and desmosomes. Endothelial cells situated in glomeruli and along blood vessels were identified by their locations and the presence of Weibel-Palade bodies in their cytoplasms (53). Mouse kidneys were removed and fixed in 4% paraformaldehyde in PBS (pH 7.4) immediately after sacrifice. Tissues were then embedded in paraffin and sectioned. Sections were deparaffinized, rehydrated, stained with hematoxylin-eosin and silver methenamine, and examined for glomerular, tubular, interstitial, and vascular changes. Sections used for TUNEL assay were deparaffinized and rehydrated prior to processing. Four sections from each mouse kidney were studied by the TUNEL assay. Adjacent sections were used for examination by light microscopy and TUNEL analysis. Sections used for TEM were fixed and prepared as described below.TUNEL assay. The TUNEL method was based on a modified protocol from Gavrieli et al. (12, 41). TUNEL labeling was defined as positive when cells were highly fluorescent against a background of lightly stained cells. Assay controls were performed by preincubation of sections with 1 µg of DNase (Boehringer, Mannheim, Germany) per ml for 10 min and resulted in strong positive labeling of all visible cells. Omission of the biotin-labeled nucleotide resulted in no detectable signal.
HRTEC. Human renal tubular epithelial cells (HRTEC) were isolated from the kidney of a 3-year-old boy whose kidney was removed due to hydronephrosis and reduced function. The removal of part of the renal tissue for research purposes was approved by the ethics committee of the University of Lund. The child was not taking medications prior to or at the time of the operation and had a slightly elevated blood pressure (120/80). The renal cortex was macroscopically thinner than normal. The cortex was dissected from the renal medulla. The cortical cells were isolated according to the method described for human renal microvascular endothelial cells (HRMEC) (37, 54). Briefly, the cortical fragments were incubated overnight in a buffer containing 0.1% collagenase type I (Sigma, Stockholm, Sweden) and 0.04% DNase IV (Sigma). The tissue was applied to the top of a two-step Percoll gradient (Pharmacia Biotech, Stockholm, Sweden), and the interface between the two steps was collected, centrifuged, and resuspended in Primaria flasks (Falcon, Stockholm, Sweden) in Dulbecco's modified Eagle's medium (GIBCO, Täby, Sweden) supplemented with 15% fetal calf serum (GIBCO), 2 mM L-glutamine (GIBCO), 20 U of heparin (Pharmacia) per ml, 100 U of penicillin per ml, and 100 µg of streptomycin per ml (both from GIBCO). Cells were incubated at 37°C in an atmosphere of 95% air and 5% CO2 and grown to confluence. After trypsinization, the cell suspension was filtered through a 35-µm-pore-size nylon mesh and cells passaged through the net were replated in Primaria flasks and grown to confluence. The cell isolates were trypsinized, concentrated in fetal calf serum containing 5% dimethyl sulfoxide (Merck, Darmstadt, Germany), and stored in liquid nitrogen for subsequent use. Cells used in experiments were passaged three to five times and cultured in Primaria flasks or in 24-well Primaria plates in medium with supplements and 1% endothelial cell growth factor (Sigma).
By light microscopy, more than 90% of the cells had similar morphologies. These cells were characterized and confirmed as epithelial cells by positive staining for cytokeratins (35) with MNF116 (Dako) and CAM 5.2 (Becton Dickinson, San Jose, Calif.) by the alkaline phosphatase anti-alkaline phosphatase technique. By TEM the cells exhibited tight junctions and microvilli, indicating tubular origin. These cells were therefore defined as HRTEC. The presence of leucocytes was ruled out by lack of reactivity with a MAb directed to human leucocyte common antigen. Furthermore, the cells were negative for the following endothelial cell markers: von Willebrand factor, CD31, and CD34 (all antibodies from Dako). With anti-endoglin antibody (Dako), approximately 5% of cells stained weakly. Less than 10% of cells contained Weibel-Palade bodies, as determined by TEM (53).Cell stimulants. (i) Stx. Purified Stx was kindly provided by A Lindberg (Department of Microbiology, Karolinska Institute, Huddinge, Sweden). The LPS content of the Stx preparation was 2 endotoxin units (EU)/ml at a Stx concentration of 1 µg/ml as tested by the Limulus amebocyte lysate assay (Coatest; Chromogenix, Gothenburg, Sweden), which has a detection level of 0.04 EU/ml.
(ii) Polymyxin extracts.
E. coli O157:H7 86-24 and
87-23 and the control E. coli strain FN414 were used for
cell stimulation. The bacteria were cultured overnight on tryptic soy
agar plates, scraped off the plates, and harvested into PBS-A (0.12 M
NaCl, 0.03 M phosphate, 0.02% NaN3 [pH 7.2]) with
polymyxin B sulfate (2 mg/ml; Dumex, Copenhagen, Denmark) diluted to a
weight of 50 mg of bacteria/ml of PBS-A and incubated for 30 min at
37°C. The supernatant was collected after centrifugation at 400 × g for 10 min, and the cytotoxic concentration was
determined by a modified Vero cell assay at dilutions of 1/10 to
1/1,280 (13, 21, 42). The polymyxin B sulfate extract of
E. coli 86-24 was cytotoxic for Vero cells at dilutions of
160. Extracts of E. coli 87-23 and FN414 did not affect
the Vero cells. The LPS content of each of the bacterial extracts was
over 10,000 EU/ml as tested by the Limulus amebocyte lysate
assay. The LPS content of polymyxin B sulfate in PBS-A was 4 to 7 EU/ml.
Cell stimulation assays.
Epithelial cells were grown to
confluency in 24-well Primaria plates or in Primaria flasks. At time
zero, cells were washed in PBS and the culture medium was removed and
replaced with endothelial serum-free medium (GIBCO) supplemented with 2 mM L-glutamine, 20 U of heparin (Pharmacia) per ml, 100 U
of penicillin per ml, 100 µg of streptomycin per ml (both from
GIBCO), and 1% endothelial cell growth factor (Sigma) with or without
40 ng of tumor necrosis factor alpha (TNF-
; Knoll; BASF,
Ludwigshafen, Germany) per ml. At 24 h cells were stimulated
with Stx (100 ng/ml to 1 pg/ml) or polymyxin B sulfate extracts at a
1/40 dilution of E. coli strain 86-24, 87-23, or FN414.
Dilutions were prepared in endothelial serum-free medium with
supplements. Control cells were left unstimulated or exposed to
polymyxin B sulfate (2 mg/ml of PBS-A). Supernatants were taken 24 h after addition of stimulant. Cells were removed by centrifugation at
250 × g. The remaining cells were detached with EDTA
(0.2 g/liter of PBS) or trypsin. Cells were combined and subjected to
DNA analyses or fixed for electron microscopy. For each stimulant, cell
experiments were carried out twice.
TEM. Mouse kidneys and HRTEC were double fixed in 2.5% glutaraldehyde and 1% osmium tetroxide (both diluted in 0.1 M Sörensen buffer), embedded in agar 100 (Link, Stockholm, Sweden), poststained with 4% uranyl acetate and 2% lead citrate (both from Kebo, Stockholm, Sweden), sectioned, and examined by TEM.
DNA fragmentation.
High-molecular-weight DNA fragments were
detected by field-inversion gel electrophoresis (FIGE) as described
previously (55). DNA size calibration was performed with two
sets of pulse markers: chromosomes from Saccharomyces
cerevisiae (225 to 2,200 kbp) and a mixture of
DNA
HindIII fragments,
DNA, and
DNA concatemers (0.1 to 200 kbp) purchased from Sigma. DNA was visualized under UV light
(305 nm) after being stained with ethidium bromide (6 µg/ml) and was
photographed with Polaroid 55 positive-negative film.
Detection of apoptosis. Tissue apoptosis in vivo was detected by the TUNEL assay and TEM. Apoptosis of cultured renal cells in vitro was detected by TEM and FIGE.
Statistics.
Differences in the number of TUNEL-positive
cells between mice inoculated with Stx-2-positive strains and mice
inoculated with Stx-2-negative strains were evaluated by the Student
t test. A P of
0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Histopathology of human renal cortical tissue. Histopathology of the biopsy from the HUS patient showed extensive renal cortical necrosis (pathological definition). The 10 glomeruli visualized in the biopsy had capillaries filled with thrombi. Cell proliferation was noted in one glomerulus. Blood vessels were dilated and filled with thrombi. Extensive damage to tubular epithelial cells, including pyknotic cell nuclei and fragments of nuclei, was noted. Tubular luminae were filled with these fragments as well as fibrin and erythrocytes (Fig. 1A and B). The interstitium was widened. Immunofluorescence for fibrinogen was strongly positive in glomerular capillaries, blood vessels, and tubuli. Renal cortical necrosis secondary to HUS was diagnosed by a renal pathologist.
|
TUNEL of human renal cortical tissue. Numerous TUNEL-positive nuclei were identified in the renal cortices from the children with HUS. Labeling was noted in the nuclei of tubular cells (Fig. 1D), and small labeled structures were present in the tubular luminae. Nuclei also stained positively in glomeruli. TUNEL-positive cells were not identified in the renal cortex of the control biopsy (Fig. 1E).
Histologic studies of mouse kidneys. Histopathology of renal sections from infected mice revealed focal proliferation of glomerular mesangial cells, increased deposition of mesangial matrix, focal interstitial influx of inflammatory cells, necrosis of tubular epithelial cells (disintegration of cytoplasms and absence of nuclei), and an abundance of erythrocytes in the blood vessels. Mice inoculated with E. coli FN414 and PBS control mice sacrificed on day 10 exhibited normal histologies.
Kidneys from mice pretreated with anti-Stx-2 antibodies and inoculated with E. coli 86BL (n = 4) exhibited fewer histopathological changes than mice that were not pretreated. Focal proliferation of glomerular mesangial cells and few inflammatory infiltrates (n = 1), minimal vascular congestion (n = 2), or no changes (n = 1) were noted.TUNEL analysis of mouse kidneys. Two patterns of labeling by TUNEL were observed in mouse renal cortices: one pattern was indicative of single fluorescent nuclei of separate cells surrounded by nonlabeled cells (Fig. 2A and B) and the other pattern was patchy fluorescence, indicative of areas of approximately 50 to 150 positively stained nuclei per patch (Fig. 2C). In addition, certain kidneys exhibited slightly positive diffuse fluorescence along their entire outer cortical borders. These border cells did not stain as brightly as cells described above but were more fluorescent than the background staining. The different patterns of labeling by TUNEL could be present in the same kidney. There was no correlation between the duration of infection and the degree of labeling.
|
|
TEM of mouse kidneys. Ultramorphological changes indicating apoptosis or necrosis were evaluated by TEM. Marked nuclear and cytoplasmic changes in tubular epithelial cells were noted for all renal cortices from symptomatic mice inoculated with Stx-2-positive strains (n = 5). Cells (5 of 10 cells) exhibited convoluted nuclei with invaginations in their nuclear membranes (Fig. 3A), chromatin condensation (2 of 10 cells) (Fig. 3B), or separation of the nuclear envelopes (1 of 20 cells) (Fig. 3C). Considerable swelling and disruption of the inner mitochondrial cristae were noted for most cells (Fig. 3B). Cells with severely damaged mitochondriae had a total lack of the brush border, and their luminal spaces were filled with granular deposits. A few endothelial cells exhibited convoluted nuclei with disruption of the nuclear membranes, but intracytoplasmic changes were not noted. A few mesangial cells exhibited convoluted nuclei, but most appeared normal. These changes in tubular epithelial, endothelial, and mesangial cells were noted for all kidneys regardless of when mice were sacrificed.
|
The effects of Stx and polymyxin extracts on HRTEC. (i) Stx.
Stx had a marked effect on the confluence, adherence, and morphology of
HRTEC. At Stx concentrations of 1 ng/ml to 10 pg/ml, considerable
dose-related cell detachment was noted by light microscopy after
24 h of stimulation. Cells that did not detach became elongated, with multiple vacuoles and prominent and less centralized nuclei. Stx
at concentrations above 1 ng/ml caused detachment of almost all cells.
Toxin concentrations below 10 pg/ml did not have a visible effect on
the cells. The effect of Stx was enhanced by prestimulation with
TNF-
.
|
(40 ng/ml) for 24 h increased the degree of
fragmentation, which was reflected in stronger high-molecular-weight bands after 24 h of toxin stimulation (Fig.
5). TNF-
alone did not induce DNA
fragmentation.
|
(ii) Polymyxin extracts.
E. coli 86-24 extract (Stx-2
positive) caused massive cell detachment after 24 h. TEM revealed
convolution of the nuclear envelope (Fig. 4B) and redistribution of
chromatin. Mitochondrial swelling and sparsity of microvilli were also
apparent. High-molecular-weight DNA fragments (294 and 50 kbp) were
formed (Fig. 5). Prestimulation of cells with TNF-
(40 ng/ml) for
24 h increased DNA fragmentation in the 50-kbp range after 24 h of stimulation with the bacterial supernatant. In contrast, E. coli 87-23 extract (Stx negative) did not cause nuclear or
intracytoplasmic changes (Fig. 4C) but high-molecular-weight DNA
fragments (294 kbp) were formed (Fig. 5) and did not increase after
TNF-
prestimulation. E. coli FN414 extract caused the
formation of high-molecular-weight DNA fragments in the 294-kbp range.
Cells stimulated with this strain were not prestimulated with TNF-
or examined by TEM. Neither morphological changes nor DNA fragmentation
was noted in cells exposed to polymyxin B sulfate in PBS-A or in
unstimulated cells (Fig. 4D).
| |
DISCUSSION |
|---|
|
|
|---|
This study examined apoptosis of renal cortical cells in the HUS. The renal cortical biopsy taken from a child with postenteropathic HUS showed extensive cortical necrosis and thrombotic microangiopathy as defined by pathology. Nuclear fragments were visualized by light microscopy, which indicated that apoptosis was taking place. TUNEL analysis revealed positive staining in the glomerular and tubular structures and in lumina. Labeling was also positive in autopsy material taken from two children with HUS. A recent study showed that processing of tissue postmortem does not, in itself, increase the degree of TUNEL-positive cells (in comparison to the degree of TUNEL-positive cells in biopsy material) (1). Taken together, these results suggest that apoptosis of renal cortical cells takes place in HUS.
Apoptotic cells were also detected in kidneys of mice with experimentally induced E. coli O157:H7 infection. Renal cortices from mice inoculated with Stx-2-positive E. coli O157:H7 exhibited high numbers of TUNEL-positive cells. The presence of patches of fluorescence and high numbers of labeled single cells indicated extensive apoptosis. Ultrastructural changes consisted of severe nuclear and cytoplasmic tubular changes. TUNEL-positive cells were also observed, albeit to a lesser degree, in mice inoculated with toxin-negative strains, and a low frequency of TUNEL-positive cells occurred in normal kidneys. TEM did not show tissue damage in mice inoculated with toxin-negative strains, but the sections represent a small portion of the renal cortex and damaged areas may have been missed. Kidneys from mice inoculated with Stx-2-positive strains showed changes in both epithelial and endothelial cells, whereas kidneys from mice infected with Stx-2-negative strains showed fewer changes and these occurred only in epithelial cells. The kidney apoptosis pattern confirmed the observations regarding human HUS and suggested that infection with Stx-2-producing E. coli was the cause of these changes.
Further studies showed a direct apoptosis-inducing effect of the bacteria and of Stx on pediatric renal cells in culture. Primary kidney cell cultures were susceptible to the cytotoxic effect of Stx-2-positive E. coli O157:H7 and purified Stx. Ultramorphology indicated that the cells were undergoing apoptosis. Furthermore, cells exposed to Stx and polymyxin extracts of Stx-2-positive E. coli O157:H7 were shown to undergo DNA fragmentation. Epithelial cells are less likely to produce typical nucleosome ladders (9), but fragments of 50 kbp represent more extensive DNA digestion. HRTEC stimulated with the polymyxin extract of the toxin-negative strain did not show morphological changes indicative of apoptosis but underwent DNA fragmentation in the higher-molecular-weight range (294 kbp). The same pattern of fragmentation was also noted for cells stimulated with the control strain. These results show that bacteria induced apoptosis in kidney cells and indicate that more than one bacterial virulence factor was involved but that when Stx was present, the damage became more pronounced.
The effect of Stx has been studied in vitro with various types of endothelial cells. A dose-dependent cytotoxic effect was found when human umbilical vein endothelial cells were stimulated with purified Stx (36). These results have since then been confirmed in several studies which found that Stx-1 and Stx-2 had similar effects on endothelial cells (27, 30). The susceptibility of pediatric renal cortical tubular cells to Stx has not been previously studied. We chose to use pediatric renal cortical cells because children are more susceptible to postenteropathic HUS than adults (20). The method employed to isolate HRTEC has previously been used to isolate HRMEC from healthy adult donor kidneys (37, 54), but we obtained tubular cells after passage of cells through a net. The isolation of tubular, instead of endothelial, cells was most probably related to the fact that the pediatric kidney was removed due to disease; the cortex was thinner than normal and contained fewer endothelial cells, which resulted in overgrowth of the tubular cells in culture. Purified Stx was capable of direct cytotoxic action on HRTEC. These results, together with the results of previous studies using cultured endothelial cells (37), suggest that Stx may have separate cytotoxic activities on endothelial and epithelial cells of the renal cortex.
The cytotoxic effect of Stx on endothelial cells has been ascribed to inhibition of protein synthesis (27, 38, 43). In a previous study, Stx was found to induce apoptosis and inhibit protein synthesis in Burkitt lymphoma cells (31). The cells underwent apoptosis not only by stimulation with the holotoxin but also by stimulation with the B subunit which enables binding of the toxin to the globotriaosylceramide (Gb3) receptor but does not inhibit protein synthesis (31). Thus, binding to the cell membrane may transduce an apoptotic signal even before the toxin becomes internalized and inhibits protein synthesis. HRMEC have been found to express more Gb3 receptors than human umbilical vein endothelial cells (37) and are more susceptible to the cytotoxic effects of Stx-2 than to those of Stx-1 (30). A recent study using human glomerular microvascular endothelial cells did not, however, find a difference in the degree of protein synthesis inhibition between these two toxins (50). This may indicate that the cytotoxic effect is initiated prior to the cessation of protein synthesis. The precise mechanism by which Stx induces apoptosis in renal cortical cells needs to be addressed.
The tubular epithelial cell injury in vivo may be a direct effect of
circulating bacterial virulence factors and/or host response molecules
but may also be secondary to changes in the renal blood flow due to
endothelial cell damage. In vitro studies have shown that the cytotoxic
effect increased when endothelial cells were stimulated with a
combination of Stx and TNF-
(29) or prestimulated with
TNF-
(27, 29, 37, 49). Prestimulation of these cells resulted in an increase in Gb3 receptors, rendering the cells more
susceptible to the cytotoxic effect of Stx or Stx-1 (27, 37,
49). In this study, prestimulation of cells with TNF-
was
shown to enhance the apoptosis-inducing effect of Stx whereas exposure
to TNF-
alone did not lead to apoptosis. We have previously shown
that TNF-
is present in the urinary tracts of patients with HUS
(23). Thus, bacterial factors may act in concert with host
cytokines in vivo, increasing the degree of apoptosis and tissue
injury.
The mechanisms by which infection with Stx-producing E. coli induces renal cortical injury in vivo have not been elucidated. In this study we have shown that apoptotic cell death occurs in the renal cortex during HUS. Stx and other E. coli O157:H7 factors were found to induce this process in vitro. Thus, induction of apoptosis may contribute to the renal damage in HUS. A better understanding of the factors involved in this form of tissue injury may lead to new perspectives for therapy.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by grants from the Swedish Medical Research Council (grant numbers 7934 and 12209); the Swedish Medical Society; the Medical Faculty, University of Lund and the Lund University Hospital; the Samariten Foundation, Sachska Children's Hospital, Stockholm, Sweden; the Carl J. Michaelsen donation fund; and the Swedish Society for Medical Research.
We thank Per Alm, Department of Pathology, University of Lund, for biopsy material; Bernard Kaplan and David Carpentieri, Children's Hospital of Philadelphia, for postmortem material; and Lena Sandell, Karin Arnér, Ingela Larsson, Katarzyna Said, Christina Pehrson, and Christina Andersson for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pediatrics, University of Lund, 22185 Lund, Sweden. Phone: 46-46-171000. Fax: 46-46-145459. E-mail: diana.karpman{at}mmb.lu.se.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bardales, R. H., S.-S. Xie, and S.-M. Hsu. 1997. In situ DNA fragmentation assay for detection of apoptosis in paraffin-embedded tissue sections. Am. J. Clin. Pathol. 107:332-336[Medline]. |
| 2. | Barrett, T. J., M. E. Potter, and I. K. Wachsmuth. 1989. Continuous peritoneal infusion of Shiga-like toxin-II (SLT-II) as a model for SLT-II-induced diseases. J. Infect. Dis. 159:774-777[Medline]. |
| 3. |
Boyce, T. G.,
D. L. Swerdlow, and P. M. Griffin.
1995.
Escherichia coli O157:H7 and the hemolytic uremic syndrome.
N. Engl. J. Med.
333:364-368 |
| 4. | Caprioli, A., I. Luzzi, F. Rosmini, P. Pasquini, R. Cirrincione, A. Gianviti, M. C. Matteucci, G. Rizzoni, and the HUS Italian Study Group. 1992. Hemolytic-uremic syndrome and vero cytotoxin-producing Escherichia coli infection in Italy. J. Infect. Dis. 166:154-158[Medline]. |
| 5. | Chae, C., R. A. Moxley, J. Christopher-Hennings, D. H. Francis, and M. J. Wannemuehler. 1994. Shiga-like toxin-II-producing Escherichia coli O157:H7 infection in gnotobiotic piglets: protection against brain vascular lesions with SLT-II antiserum, p. 241-244. In M. A. Karmali, and A. G. Goglio (ed.), Recent advances in verocytotoxin producing Escherichia coli infections. Elsevier Science, Amsterdam, The Netherlands. |
| 6. |
Chang, M. P.,
J. Bramhall,
S. Graves,
B. Bonavida, and B. J. Wisnieski.
1989.
Internucleosomal DNA cleavage precedes Diphtheria toxin-induced cytolysis.
J. Biol. Chem.
264:15261-15267 |
| 7. | Chart, H., H. R. Smith, S. M. Scotland, B. Rowe, D. V. Milford, and C. M. Taylor. 1991. Serological identification of Escherichia coli O157:H7 infection in haemolytic uremic syndrome. Lancet 337:138-140[Medline]. |
| 8. | Chen, Y., M. R. Smith, K. Thirumalai, and A. Zychlinsky. 1996. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15:3853-3860[Medline]. |
| 9. | Eastman, A. 1995. Assays for DNA fragmentation, endonucleases, and intracellular pH and Ca2+ associated with apoptosis, p. 41-55. In L. M. Schwarz, and B. A. Osborne (ed.), Cell death. Academic Press, San Diego, Calif. |
| 10. | Fitzpatrick, M. M., M. D. S. Walters, R. S. Trompeter, M. J. Dillon, and T. M. Barratt. 1993. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. J. Pediatr. 122:532-537[Medline]. |
| 11. |
Francis, D. H.,
J. E. Collins, and J. R. Duimstra.
1986.
Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.
Infect. Immun.
51:953-956 |
| 12. |
Gavrieli, Y.,
Y. Sherman, and S. A. Ben-Sasson.
1992.
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
J. Cell Biol.
119:493-501 |
| 13. |
Gentry, M. K., and J. M. Dalrymple.
1980.
Quantitive microtiter cytotoxicity assay for Shigella toxin.
J. Clin. Microbiol.
12:361-366 |
| 14. | Griffin, P. M. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Cuerrant (ed.), Infections of the gastrointestinal tract. Raven Press Ltd., New York, N.Y. |
| 15. | Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. Ann. Intern. Med. 109:705-712. |
| 16. | Habib, R. 1992. Pathology of the hemolytic uremic syndrome, p. 315-353. In B. S. Kaplan, R. S. Trompeter, and J. L. Moake (ed.), Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Marcel Dekker Inc., New York, N.Y. |
| 17. |
Hagberg, L.,
I. Engberg,
R. Freter,
J. Lam,
S. Olling, and C. Svanborg-Edén.
1983.
Ascending unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
Infect. Immun.
40:273-283 |
| 18. | Harel, Y., M. Silva, B. Giroir, A. Weinberg, T. B. Cleary, and B. Beutler. 1993. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by Shiga-like toxin. J. Clin. Invest. 92:2110-2116. |
| 19. | Inward, C. D., J. Williams, I. Chant, J. Crocker, D. V. Milford, P. E. Rose, and C. M. Taylor. 1995. Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. 30:213-218[Medline]. |
| 20. | Kaplan, B. S. 1991. Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, p. 326-329. In H. R. Jacobson, G. E. Striker, and S. Klahr (ed.), The principles and practice of nephrology. B. C. Decker, Philadelphia, Pa. |
| 21. |
Karmali, M. A.,
M. Petric,
C. Lim,
R. Cheung, and G. S. Arbus.
1985.
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin.
J. Clin. Microbiol.
22:614-619 |
| 22. | Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782[Medline]. |
| 23. | Karpman, D., A. Andreasson, H. Thysell, B. S. Kaplan, and C. Svanborg. 1995. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr. Nephrol. 9:694-699[Medline]. |
| 24. | Karpman, D., H. Connell, M. Svensson, F. Scheutz, P. Alm, and C. Svanborg. 1997. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175:611-620[Medline]. |
| 25. | Keenan, K. P., D. D. Sharpnack, H. Collins, S. B. Formal, and A. D. O'Brien. 1986. Morphologic evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. Am. J. Pathol. 125:69-80[Abstract]. |
| 26. | Kerr, J. F. R., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257[Medline]. |
| 27. | Keusch, G. T., D. W. K. Acheson, L. Aaldering, J. Erban, and M. S. Jacewicz. 1996. Comparison of the effects of Shiga-like toxin I on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells. J. Infect. Dis. 173:1164-1170[Medline]. |
| 28. | Levin, M., and T. M. Barratt. 1984. Haemolytic uraemic syndrome. Arch. Dis. Child. 59:397-400[Medline]. |
| 29. |
Louise, C. B., and T. G. Obrig.
1991.
Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 , and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
Infect. Immun.
59:4173-4179 |
| 30. | Louise, C. B., and T. G. Obrig. 1995. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. J. Infect. Dis. 172:1397-1401[Medline]. |
| 31. |
Mangeney, M.,
C. A. Lingwood,
S. Taga,
B. Caillou,
T. Tursz, and J. Wiels.
1993.
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Cancer Res.
53:5314-5319 |
| 32. | McConkey, D. J., P. Nicotera, and S. Orrenius. 1994. Signaling and chromatin fragmentation in thymocyte apoptosis. Immunol. Rev. 142:343-363[Medline]. |
| 33. | McKee, M. L., and A. D. O'Brien. 1995. Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli. Infect. Immun. 63:2070-2074[Abstract]. |
| 34. |
Mitra, D.,
E. A. Jaffe,
B. Weksler,
K. A. Hajjar,
C. Soderland, and J. Laurence.
1997.
Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells.
Blood
89:1224-1234 |
| 35. | Moll, R., W. W. Franke, and D. L. Schiller. 1982. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24[Medline]. |
| 36. |
Obrig, T. G.,
P. J. Del Vecchio,
J. E. Brown,
T. P. Moran,
B. M. Rowland,
T. K. Judge, and S. W. Rothman.
1988.
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
Infect. Immun.
56:2373-2378 |
| 37. |
Obrig, T. G.,
C. B. Louise,
C. A. Lingwood,
B. Boyd,
L. Barley-Maloney, and T. O. Daniel.
1993.
Endothelial heterogeneity in Shiga toxin receptors and responses.
J. Biol. Chem.
268:15484-15488 |
| 38. | Obrig, T. G., T. P. Moran, and J. E. Brown. 1987. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem. J. 244:287-294[Medline]. |
| 39. |
Pai, C. H.,
J. K. Kelly, and G. L. Meyers.
1986.
Experimental infection of infant rabbits with verotoxin-producing Escherichia coli.
Infect. Immun.
51:16-23 |
| 40. |
Perera, L. P.,
L. R. M. Marques, and A. D. O'Brien.
1988.
Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
26:2127-2131 |
| 41. | Perez, M. R., K. Arnér, and A. Håkansson. 1997. DNA fragmentation characteristic of apoptosis and cell loss induced by kainic acid in rabbit retinas. Neurochem. Int. 31:251-260[Medline]. |
| 42. |
Petric, M.,
M. A. Karmali,
G. S. Arbus,
M. Roscoe,
S. Louie, and R. Cheung.
1987.
Effects of cycloheximide and puromycin on cytotoxic activity of Escherichia coli verocytotoxin (Shiga-like toxin).
J. Clin. Microbiol.
25:1265-1268 |
| 43. |
Reisbig, R.,
S. Olsnes, and K. Eiklid.
1981.
The cytotoxic activity of Shigella toxin.
J. Biol. Chem.
256:8739-8744 |
| 44. |
Sandvig, K.,
K. Prydz,
M. Ryd, and B. van Deurs.
1991.
Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells.
J. Cell Biol.
113:553-562 |
| 45. | Sandvig, K., and B. van Deurs. 1992. Toxin-induced cell lysis: protection by 3-methyladenine and cycloheximide. Exp. Cell Res. 200:253-262[Medline]. |
| 46. | Sjöblad, S., B. Larsson, G. Kahlmeter, and T. Wadström. 1989. Pojke fick SLT-associerat hemolytiskt uremiskt syndrom. Läkartidningen 86:2595-2596[Medline]. |
| 47. |
Tesh, V. L.,
J. A. Burris,
J. W. Owens,
V. M. Gordon,
E. A. Wadolkowski,
A. D. O'Brien, and J. E. Samuel.
1993.
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.
Infect. Immun.
61:3392-3402 |
| 48. |
Tzipori, S.,
H. Karch,
K. I. Wachsmuth,
R. M. Robins-Browne,
A. D. O'Brien,
H. Lior,
M. L. Cohen,
J. Smithers, and M. M. Levine.
1987.
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.
Infect. Immun.
55:3117-3125 |
| 49. |
van de Kar, N. C. A. J.,
L. A. H. Monnens,
M. A. Karmali, and V. W. M. van Hinsbergh.
1992.
Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
Blood
80:2755-2764 |
| 50. | van Setten, P. A., V. W. van Hinsbergh, T. J. van der Velden, N. C. van de Kar, M. Vermeer, J. D. Mahan, K. J. Assmann, L. P. van den Heuvel, and L. A. Monnens. 1997. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int. 51:1245-1256[Medline]. |
| 51. |
Wadolkowski, E. A.,
J. A. Burris, and A. D. O'Brien.
1990.
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun.
58:2438-2445 |
| 52. |
Wadolkowski, E. A.,
L. M. Sung,
J. A. Burris,
J. E. Samuel, and A. D. O'Brien.
1990.
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.
Infect. Immun.
58:3959-3965 |
| 53. |
Weibel, E. W., and G. E. Palade.
1964.
New cytoplasmic components in arterial endothelia.
J. Cell Biol.
23:101-112 |
| 54. |
Wojta, J.,
R. L. Hoover, and T. O. Daniel.
1989.
Vascular origin determines plasminogen activator expression in human endothelial cells.
J. Biol. Chem.
264:2846-2852 |
| 55. | Zhivotovsky, B., D. Wade, A. Gahm, S. Orrenius, and P. Nicotera. 1994. Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation. FEBS Lett. 351:150-154[Medline]. |
| 56. | Zychlinsky, A., M. C. Prevost, and P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||